Trials / Conditions / Postbariatric Hypoglycemia
Postbariatric Hypoglycemia
6 registered clinical trials studyying Postbariatric Hypoglycemia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI) NCT07029412 | MBX Biosciences | Phase 2 |
| Recruiting | Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metab NCT06896682 | Esbjerg Hospital - University Hospital of Southern Denmark | — |
| Completed | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects NCT06036784 | MBX Biosciences | Phase 1 |
| Completed | Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions NCT05721729 | Vogenx, Inc. | Phase 2 |
| Completed | Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects NCT05541939 | Vogenx, Inc. | Phase 2 |
| Completed | Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia NCT03373435 | Eiger BioPharmaceuticals | Phase 2 |